Last week, we warmly welcomed the Italian Society for Psychedelic Medicine (SIMEPSI) and the Ukrainian Psychedelic Research Association (UPRA) to our Community Supporters network! We look forward to our continued collaboration! tinyurl.com/3efaz5k5
PAREA has co-signed a statement by @MentalHealthEur calling on the European Commission, Parliament and Member States to deliver tangible follow-through on promises made for mental health care. Organisations can still co-sign until Dec 10: tinyurl.com/ycx4y7mm
On Saturday, PAREA attended @BelgiumSociety ‘s annual symposium, speaking about access to psychedelic medicines. The event showcased the current landscape of psychedelic therapy and research in Belgium. We were grateful for the opportunity to connect with the Belgian community!
We are proud today to be a part of the first Italian conference discussing the clinical use of psychedelics, in Rovereto. We will present on the “Legal Status of Psychedelics and Its Impact on Research and Development.”. addictionsciencelab.unitn.it…
We're thrilled to welcome Francisca Silva to our team joining us today as a Project Officer! A recent EMA trainee and neuroscientist by training, she has a dual MSc in Brain and Mind Sciences from UCL and Sorbonne Université, along with a BSc from the Maastricht Science Program
PAREA's issued a commentary on the high-level expert report on EU R&I programmes!
We highlight the urgent need for enhanced mental health funding and support, advocating for a dedicated EU mission for mental health, similar to the Cancer Mission view.flodesk.com/emails/6688…
Happy Mental Health Day! PAREA is in Geneva for the WHO Mental Health Forum. Mental health is often neglected, but global progress is very encouraging. This year's theme focuses on the link between mental health and work. Safe, healthy workplaces are essential.
PAREA regrets FDA refusal of new drug approval for MDMA-assisted therapy for PTSD, which may deprive people with PTSD of an effective treatment option
Read our full news release here:
tinyurl.com/NewsRelease-FDA-…
Today, we announced key updates on psychedelics in Europe: In a just published ENG version of its report, the Dutch State Committee endorses MDMA-assisted therapy for PTSD, and EMA publishes a comprehensive report on psychedelics. See full release here: tinyurl.com/news-NL-EMA
Today, we are welcoming a new PAREA Community Supporter: Foundation for Therapeutic Advancement and Innovation with Psychedelics. TAIP is an Estonian org that advances science-based approaches to using psychedelics in contemporary therapeutic practices sataip.ee/home











